Additionally, we found that Cory enhances the sensitivity of HCC cells to sorafenib by regulating NOS3-mediated reactive oxygen species (ROS) homeostasis and IL-18 secretion. This evidence concerns the gene IL18 and hepatocellular carcinoma.